EPKINLY Oncology Milestone: The Dawn of Next-Generation Immunotherapy for Resistant DLBCL | #abbvie dlbcl epkinly approval # epkinly replacement # epkinly cost with insurance # epkinly bispecific # epkinly and remission # epkinly for dlbcl # epkinly subcutaneous bispecific # epkinly dlbcl # epkinly coverage